Resources

Client Alerts, News Articles, Blog Posts, & Multimedia

Everything you need to know about BMD and the industry.

Client Alert: AAA Introduces AI-Assisted Arbitrator for Certain Disputes

Client Alert
April 7, 2026

The American Arbitration Association (“AAA”) recently introduced an AI-assisted arbitration platform known as the “AI Arbitrator.” The technology is designed to help streamline arbitration, particularly in two-party, documents-only construction disputes, by using artificial intelligence to analyze filings, summarize evidence, and generate draft decisions for a human arbitrator to review.

Under the AAA’s framework, AI does not replace the arbitrator; rather, it assists with reviewing submissions, identifying claims and issues, summarizing evidence, and preparing a proposed award. A human AAA arbitrator reviews, revises if necessary, and ultimately issues the final binding decision.

The platform reflects a broader effort within the ADR community to reduce costs and improve efficiency in high-volume disputes. Early AAA estimates suggest AI-assisted arbitration may resolve cases 20-25% faster and reduce costs by roughly 35% or more in certain document-based cases.

Potential Advantages

Organizations considering arbitration clauses that incorporate AI-assisted processes should evaluate several potential benefits:

  • Cost savings and efficiency: Automated analysis of pleadings and exhibits may significantly reduce the time required for case review and award drafting.
  • Faster dispute resolution: Streamlined workflows can shorten the time from filing to award in straightforward cases.
  • Improved analytical consistency: AI tools can systematically organize claims, evidence, and legal authorities, potentially improving clarity for arbitrators and parties.
  • Strategic insights before filing: AAA has also developed tools such as a “Resolution Simulator,” which can model how an arbitrator might analyze a dispute to help parties assess risk before initiating arbitration.

Potential Risks & Considerations

Despite these advantages, companies should carefully consider potential limitations before agreeing to AI-assisted arbitration:

  • Transparency concerns: Parties may not have full visibility into how AI analyzes issues or drafts its recommendations.
  • Reliance on emerging technology: AI systems may carry risks of bias, errors, or incomplete analysis if not carefully supervised.
  • Limited applicability: The current platform is designed primarily for documents-only disputes, meaning more complex matters involving live witness testimony may not be appropriate.
  • Contractual implications: Because the process is opt-in, arbitration clauses must specifically allow for AI-assisted arbitration if parties wish to use it.

Takeaway

AI-assisted arbitration represents a notable development in alternative dispute resolution. While it may offer meaningful efficiency and cost benefits – particularly for straightforward, document-based commercial disputes – companies should carefully consider whether the process aligns with their dispute resolution strategy, risk tolerance, and existing contractual provisions before electing to use it.

If you have questions about incorporating AI-assisted arbitration into dispute resolution clauses or evaluating its use in a pending dispute, please contact BMD Partner Krista Osterfeld at kwosterfeld@bmdllc.com.

AIArtificial IntelligenceArbitrationKrista Osterfeld
Client Alert

ODM to Implement Medicaid Work Requirements: What Providers and Medicaid Expansion Recipients Need to Know

March 21, 2025The Ohio Department of Medicaid (ODM) has submitted a waiver to impose work requirements for Medicaid expansion recipients. If approved, the new eligibility criteria will take effect on January 1, 2026. A federal public comment period is open until April 7, 2025.Client Alert

Ohio Appellate Court Rules in Favor of Gender-Affirming Care

March 19, 2025On March 18, 2025, the 10th District Court of Appeals in Franklin County ruled that Ohio’s House Bill (HB) 68, which restricts puberty blockers and hormone therapy for minors seeking gender-affirming care, violates the Health Care Freedom Amendment and is therefore unenforceable. The court found that the law unlawfully interferes with parental rights and medical decision-making. The case, Moe v. Yost, has been remanded, and Ohio Attorney General Dave Yost intends to appeal.Client Alert

HHS Revokes Public Comment Requirement on Certain Policy Changes

March 5, 2025The U.S. Department of Health and Human Services (HHS) has revoked the Richardson Waiver, eliminating the requirement for public notice and comment on certain policy changes. This decision allows HHS to implement new policies more quickly, potentially affecting healthcare funding rules like Medicaid work requirements. While it speeds up policymaking, it also reduces opportunities for stakeholder input, raising concerns over transparency and unintended consequences for healthcare providers, states, and patients.Client Alert

Don't Get Caught Dazed and Confused: Another Florida Court Weighs in on Employer Obligations to Accommodate Medical Marijuana Use

March 3, 2025A Florida trial court ruled in Giambrone v. Hillsborough County that employers may need to accommodate off-duty medical marijuana use under the Florida Civil Rights Act (FCRA). This contrasts with prior rulings and raises new compliance challenges for employers. With the case on appeal, now is the time to review workplace drug policies.Client Alert

Corporate Transparency Act to be Re-evaluated

February 28, 2025Recent federal rulings have impacted the enforceability of the Corporate Transparency Act (CTA), which took effect on January 1, 2024. While reporting requirements were briefly reinstated, FinCEN has now paused enforcement and is reevaluating the CTA. Businesses are no longer required to submit reports until further guidance is issued. For updates and legal counsel, contact BMD Member Blake Gerney.
Older posts
Newer posts